Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5412471 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5406861 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5406792 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5414617 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5412524 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5408876 | 0.98 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL19677889 | 0.95 | DNM1 (0.48) | DNM1GPR84PLA2G1BPLA2G2AFFAR4 | |
| SCHEMBL5423731 | 0.91 | DNM1 (0.41) | DNM1GPR84PLA2G1BPLA2G2AL3MBTL1 | |
| SCHEMBL18789543 | 0.89 | GPR84 (0.43) | GPR84PLA2G1BPLA2G2AFFAR4FFAR1 | |
| SCHEMBL29234717 | 0.87 | GPR84 (0.44) | GPR84PLA2G1BPLA2G2AFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230001011-A1 | NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS | TRUSTEES OF TUFTS COLLEGE | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230001011-A1 | NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS | PLTP, CETP, FABP1 | DNM1 3098/4885GPR84 3486/4885PLA2G1B 1128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.